The Effectiveness of Marine Based Fatty Acid Compound and NSAIDs for the Treatment of Canine Osteoarthritis: A Preliminary Study
World Small Animal Veterinary Association World Congress Proceedings, 2015
I. Kwananocha1; M. Vijarnsorn1; N. Kashemsant2; C. Lekcharoensuk1
1Department of Companion Animals Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand; 2Department of Physiology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand


NSAIDs remains a gold standard for treatment of canine osteoarthritis. PCSO-524, a marine based fatty acid compound, is an alternative treatment. However, the benefits of this agent are still debated.


To evaluate the effectiveness between PCSO-524 and NSAIDs by force plate gait analysis in canine osteoarthritis.


A prospective, randomized, single blinded study was conducted. Thirty dogs with hip or stifle osteoarthritis were randomly assigned into 3 treatment groups; PCSO-524, NSAIDs and a combination between NSAIDs and PCSO-524 (NSAIDs-PCSO). Each group received the therapeutic agent orally for 4 weeks. Peak vertical force (PVF), hematology and blood chemistry values were evaluated at prior to treatment, the 2nd and the 4th week post-treatment.


Between group comparisons using repeated measurement demonstrated indifferences of PVF, hematology and blood chemistry values. Interestingly, within group analyses revealed the PVF at prior to treatment and the end of study being significantly increased in all groups (p < 0.05). The changes of PVF were; 3.88 ± 1.35, 4.23 ± 0.74, 5.36 ± 0.94% BW, in PCSO-524, NSAIDs and NSAIDs-PCSO groups, respectively. The BUN value in NSAIDs group tended to increase when compared to baseline values (p < 0.05). However, all BUN values were within normal limit.


Even though the increased PVF were demonstrated in all treatment groups, the highest change was significantly demonstrated in the combination between NSAIDs and PCSO-524 group. This may imply beneficial effects of PCSO-524 in combination with NSAIDs. Long term aggregated data with a higher dosage should be further explored.


Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

I. Kwananocha
Department of Companion Animals Clinical Sciences
Faculty of Veterinary Medicine
Kasetsart University
Bangkok, Thailand

MAIN : Orthopedic : Fatty Acid Compound & NSAIDs for Osteoarthritis
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616


  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357